SEC Form D filing

Enveric Biosciences, Inc., 2026-05-04

An SEC Form D private-offering notice from Cambridge, MA, a $5,000,002 filer-stated offering target in Biotech. Filed 2026-05-04. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Enveric Biosciences, Inc. site↗ Verified via SEC Form D

Nasdaq listed clinical stage biotech developing neuroplastogenic small molecule therapeutics for neuropsychiatric disorders

Filed 2026-05-04Filed to raise $5,000,002First money in 2026-04-17Raised so far $5,000,002HQ (as filed) Cambridge, MASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified enveric.com↗Named in the filing 7 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source